Insulin-like growth factors-1 and -2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor-A secretion by monkey granulosa cells from preovulatory follicles

Biology of Reproduction

Volumn 68, Issue 4, 2003, Pages 1112-1118

  Martinez Chequer, J C ^a   Stouffer, R L ^a,b   Hazzard, T M ^a   Patton, P E ^b   Molskness, T A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Corpus luteum; Granulosa cells; Growth factors; Ovary; Ovulation

Indexed keywords

CHORIONIC GONADOTROPIN; COBALT CHLORIDE; GONADOTROPIN; OXYGEN; SOMATOMEDIN B; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; DNA CONTENT; DOSE RESPONSE; FEMALE; GRANULOSA CELL; HYPOXIA; NONHUMAN; OVARY; OVARY FOLLICLE; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; ANOXIA; CHORIONIC GONADOTROPIN; COBALT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; FOLLICULAR PHASE; GRANULOSA CELLS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MACACA MULATTA; OSMOLAR CONCENTRATION; OVARIAN FOLLICLE; OXYGEN; PROTEIN ISOFORMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; FALLOPIA; MACACA MULATTA; PRIMATES;

EID: 0037378658     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.011155     Document Type: Article

References (41)

1. Zelinski-Wooten MB, Chandrasekher YA, Stouffer RL. Duration, amplitude, and specificity of the midcycle gonadotropin surge in non-human primates. In: Adashi EY (ed.), Ovulation. Evolving Scientific and Clinical Concepts. New York: Springer-Verlag; 2000: 98-109.
2. Hazzard TM, Stouffer RL. Angiogenesis in ovarian follicular and luteal development. In: Arulkumaran S (ed.), Clinical Obstetrics & Gynaecology. Angiogenesis in the Female Reproductive Tract. London: Bailliere Tindall; 2000: 883-900.
3. Ferrara N, Chen H, Davis-Smyth T, Gerber H-P, Nguyen T-H, Peers D, Chisholm V, Hillan KJ, Schwall RH. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat Med 1998; 4: 336-340.
4. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA, Bicknell R. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 2000; 141:995-1000.
5. Hazzard TM, Xu F, Stouffer RL. Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biol Reprod 2002; 67:1305-1312.
6. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am J Pathol 1995; 146: 157-165.
7. Christenson LK, Stouffer RL. Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. J Clin Endocrinol Metab 1997; 82: 2135-2142.
8. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznik AJ. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 1992; 131:254-260.
9. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359:843-845.
10. Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK, Charnock-Jones DS. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 2000; 85:402-409.
11. Robinson CJ, Stringer SE. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001; 114:853-865.
12. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC. The insulin-related ovarian regulatory system in health and disease. Endocr Rev 1999; 20:535-582.
13. Bermont L, Lamielle F, Lorchel F, Fauconnet S, Esumi H, Weisz A, Adessi GL. Insulin up-regulates vascular endothelial growth factor and stabilizes its messengers in endometrial adenocarcinoma cells. J Clin Endocrinol Metab 2001; 86:363-368.
14. Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard A-L, Liu J-L, Albertsson-Wikland K, Carlsson B, Niklasson A, Sjodell L, LeRoith D, Senger DR, Smith LEH. Low IGF-1 suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A 2001; 98:5804-5808.
15. Molskness TA, VandeVoort CA, Stouffer RL. Stimulatory and inhibitory effects of prostaglandins on the gonadotropin-sensitive adenylate cyclase in the monkey corpus luteum. Prostaglandins 1987; 34:279-290.
16. National Academy of Sciences.Guide for the Care and Use of Laboratory Animals. Washington: National Academy Press; 1996.
17. Chaffin CL, Stouffer RL. Expression of matrix metalloproteinases and their tissue inhibitor messenger ribonucleic acids in macaque periovulatory granulosa cells: time course and steroid regulation. Biol Reprod 1999; 61:14-21.
18. Duffy DM, Chaffin CL, Stouffer RL. Expression of estrogen receptor a and β in the rhesus monkey corpus luteum during the menstrual cycle: regulation by luteinizing hormone and progesterone. Endocrinology 2000; 141:1711-1717.
19. Brannian JD, Stouffer RL. Native and modified (acetylated) low density lipoprotein-supported steroidogenesis by macaque granulosa cells collected before and after the ovulatory stimulus: correlation with fluorescent lipoprotein uptake. Endocrinology 1993; 132:591-597.
20. Brasaemle DL, Attie AD. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes. Biotechniques 1988; 6: 418-419.
21. Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 1997; 138:4748-4756.
22. Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C. Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol 1997; 78:57-70.
23. Giordano FJ, Johnson RS. Angiogenesis: the role of the microenvironment in flipping the switch. Curr Opin Genet Dev 2001; 11:35-40.
24. Hibbert ML, Stouffer RL, Wolf DP, Zelinski-Wooten MF. Midcycle administration of a progesterone synthesis inhibitor prevents ovulation in primates. Proc Natl Acad Sci U S A 1996; 93:1897-1901.
25. Phillips HS, Hains J, Leung DW, Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 1990; 127:965-967.
26. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996; 81:353-359.
27. Fischer B, Kunzel W, Kleinstein J, Gips H. Oxygen tension in follicular fluid falls with follicle maturation. Eur J Obstet Gynecol Reprod Biol 1992; 43:39-43.
28. Van Blerkom J, Antczak M, Schrader R. The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod 1997; 12:1047-1055.
29. Koos RD. Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biol Reprod 1995; 52: 1426-1435.
30. Molskness TA, Stouffer RL. Hypoxia, but not gonadotropin, stimulates vascular endothelial growth factor production by primate luteal cells in vitro. Biol Reprod 2002; 66(suppl 1):283-284(abstract 457).
31. Friedman CI, Danforth DR, Herbosa-Encarnacion C, Arbogast L, Alak BM, Seifer DB. Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril 1997; 68:607-612.
32. D'Angelo G, Ladoux A, Frelin C. Hypoxia-induced transcriptional activation of vascular endothelial growth factor is inhibited by serum. Biochem Biophys Res Commun 2000; 267:334-338.
33. Olsson J-H, Carlsson B, Hillensjo T. Effect of insulin-like growth factor I on deoxyribonucleic acid synthesis in cultured human granulosa cells. Fertil Steril 1990; 54:1052-1057.
34. Bondy CA, Zhou J. Functional correlates of IGF system gene expression in the murine and primate ovary. In: LeRoith D (ed.), The Role of Insulin-Like Growth Factors in Ovarian Physiology. Rome: Ares-Serono Symposia; 1996: 59-69.
35. Willis D, Franks S. Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J Clin Endocrinol Metab 1995; 80:3788-3790.
36. Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocr Rev 2001; 22:818-835.
37. Volpert O, Jackson D, Bouck N, Linzer DI. The insulin-like growth factor II/mannose 6-phosphate receptor is required for proliferin-induced angiogenesis. Endocrinology 1996; 137:3871-3876.
38. Giudice LC. Insulin-like growth factor family in Graafian follicle development and function. J Soc Gynecol Invest 2001; 8:S26-S29.
39. Khamsi F, Roberge S, Yavas Y, Lacanna IC, Zhu X, Wong J. Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis. Endocrine 2001; 16: 151-165.
40. Zimmermann RC, Xiao E, Bohlen P, Ferin M. Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology 2002; 143:2496-2502.
41. Spanel-Borowski K, Schafer I, Zimmermann S, Engle W, Adham IM. Increase in final stages of follicular atresia and premature decay of corpora lutea in Ins13-deficient mice. Mol Reprod Dev 2001; 58:281-286.